ACE and hydrops fetalis: Whilst, the use of angiotensin converting enzyme inhibitors, angiotensin receptor antagonists and aldosterone antagonists provides clear benefit in HF, evidence for an anti-fibrotic action in patients is limited (Brilla et al., 2003; Kitzman et al., 2010).